L3VLUP
ProSign in

AMGN in the 13F filings

Amgen Inc · CUSIP 031162100

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 31 Oct 2024
Managers listing it
21
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 17 listed it in both
Shares listed
27,259,259
combined, among listed positions
Reported value
$8.8bn
combined, at the quarter end

Among the 94 comparable managers: 16 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing AMGN in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

21 of 21 holders

ActionFiling
Janus Henderson Group Ltd5,143,330$1.7bn0.85%Added+538,54514 Nov 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc4,546,406$1.5bn0.17%Added+24,79214 Nov 2024 (the filing on sec.gov)
Fidelity (FMR LLC)4,247,304$1.4bn0.08%Added+181,7035 Nov 2026 (the filing on sec.gov)
Capital Research Global Investors4,050,406$1.3bn0.27%Added+45,94413 Nov 2024 (the filing on sec.gov)
Invesco Ltd3,617,113$1.2bn0.23%Added+343,35112 Nov 2024 (the filing on sec.gov)
AllianceBernstein LP1,396,356$450m0.15%Trimmed-161,45414 Nov 2024 (the filing on sec.gov)
Two Sigma Advisers LP784,900$253m0.59%Added+68,00014 Nov 2024 (the filing on sec.gov)
Marshall Wace LLP705,111$227m0.28%Added+48,61314 Nov 2024 (the filing on sec.gov)
Neuberger Berman Group LLC626,974$202m0.16%Added+427,80614 Nov 2024 (the filing on sec.gov)
Capital World Investors466,652$150munder 0.1%Newnew13 Nov 2024 (the filing on sec.gov)
Two Sigma Investments LP358,741$116m0.25%Trimmed-183,40714 Nov 2024 (the filing on sec.gov)
Woodline Partners LP307,950$99m0.84%Added+15,81714 Nov 2024 (the filing on sec.gov)
Balyasny Asset Management LLC298,248$96m0.16%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Man Group PLC275,260$89m0.23%Added+47,13214 Nov 2024 (the filing on sec.gov)
D. E. Shaw & Co.166,446$54munder 0.1%Trimmed-140,23414 Nov 2024 (the filing on sec.gov)
AQR Capital Management LLC120,743$39m0.05%Addedn.a.14 Nov 2024 (the filing on sec.gov)
ARK Investment Management LLC76,614$25m0.23%Added+1,79331 Oct 2024 (the filing on sec.gov)
Farallon Capital Management LLC47,000$15m0.07%Trimmed-185,00014 Nov 2024 (the filing on sec.gov)
Dodge & Cox14,282$4.6munder 0.1%Trimmed-10013 Nov 2024 (the filing on sec.gov)
Caxton Associates LLP5,674$1.8m0.07%Added+3,31014 Nov 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP3,749$1.2munder 0.1%Newnew14 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
21 in Q3 2024 to 23 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
AMGN by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201321$17.1bnn.a.n.a.
Q3 201319$19.1bnn.a.n.a.
Q4 201322$19.9bnn.a.n.a.
Q1 201417$22.0bnn.a.n.a.
Q2 201424$20.5bnn.a.n.a.
Q3 201427$24.1bnn.a.n.a.
Q4 201424$28.1bnn.a.n.a.
Q1 201526$28.3bnn.a.n.a.
Q2 201528$26.3bnn.a.n.a.
Q3 201532$23.9bnn.a.n.a.
Q4 201531$27.5bnn.a.n.a.
Q1 201629$24.2bnn.a.n.a.
Q2 201628$23.0bnn.a.n.a.
Q3 201631$24.6bnn.a.n.a.
Q4 201625$20.3bnn.a.n.a.
Q1 201731$23.4bnn.a.n.a.
Q2 201725$25.2bnn.a.n.a.
Q3 201725$27.3bnn.a.n.a.
Q4 201726$24.5bnn.a.n.a.
Q1 201824$20.4bnn.a.n.a.
Q2 201820$26.9bnn.a.n.a.
Q3 201819$21.2bnn.a.n.a.
Q4 201820$18.9bnn.a.n.a.
Q1 201928$17.0bnn.a.n.a.
Q2 201922$14.5bnn.a.n.a.
Q3 201926$16.4bnn.a.n.a.
Q4 201921$18.7bnn.a.n.a.
Q1 202021$14.2bnn.a.n.a.
Q2 202020$16.2bnn.a.n.a.
Q3 202016$16.3bnn.a.n.a.
Q4 202019$14.0bnn.a.n.a.
Q1 202116$14.5bnn.a.n.a.
Q2 202123$13.8bnn.a.n.a.
Q3 202124$11.6bnn.a.n.a.
Q4 202121$10.4bnn.a.n.a.
Q1 202223$9.9bnn.a.n.a.
Q2 202228$9.7bnn.a.n.a.
Q3 202221$7.9bnn.a.n.a.
Q4 202224$9.3bnn.a.n.a.
Q1 202322$8.4bnn.a.n.a.
Q2 202326$7.4bnn.a.n.a.
Q3 202326$8.7bnn.a.n.a.
Q4 202324$8.4bn1411
Q1 202425$6.7bn1015
Q2 202420$8.0bn119
Q3 202421$8.8bn165
Q4 202420$8.2bn137
Q1 202525$12.0bn1016
Q2 202520$10.2bn138
Q3 202517$10.4bn89
Q4 202519$18.0bn1322
Q1 202615$21.4bn1715
Q2 202623$24.9bn1913

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

AMGN and GILD →AMGN and ARGX →AMGN and RVMD →Choose a stock to compare with AMGN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own AMGN, latest filings →Back to the 13F Explorer →